nasopharynx

Liquid surrounding the mouse brain carries dissolved waste out of the skull via a pathway down into the nasopharynx and surrounding lymph nodes in the neck. Supporting this pathway in old age may reduce the risk of age-associated neurodegenerative diseases.

FDA approves the first treatment for nasopharyngeal carcinoma, a rare cancer that originates in the nasopharynx. The drug (toripalimab-tpzi) is a next-generation, programmed death receptor-1 monoclonal antibody. Because of the tumor's location (behind the nose), surgery is not usually an option.